Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;99(12):1121-1128.
doi: 10.1097/PHM.0000000000001500.

Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice

Maricela Rodríguez-Cruz  1 , Tomas Almeida-Becerril, Salvador Atilano-Miguel, Alan Cárdenas-Conejo, Mariela Bernabe-García
Affiliations

Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice

Maricela Rodríguez-Cruz et al. Am J Phys Med Rehabil. 2020 Dec.

Abstract

Objective: In Duchenne muscular dystrophy, creatine kinase and transaminases are released into the circulation, indicating muscle injury. Their usefulness in monitoring muscle injury or disease progression has not yet been fully evaluated. Thus, this study examined serum creatine kinase and transaminase concentrations at different ages in patients with Duchenne muscular dystrophy and evaluated their association with muscle injury.

Design: This is a prospective cohort study that included 110 patients with Duchenne muscular dystrophy categorized by age groups. Creatine kinase and transaminases were quantified in the serum; the Vignos scale evaluated the muscle function.

Results: Creatine kinase and transaminase levels were higher in ambulatory than that in nonambulatory patients, which significantly decreased as age increased. Serum creatine kinase and transaminase concentrations were elevated in all ages, and those aged 3-4 yrs had the highest concentrations. Age and Vignos Scale were significantly correlated with creatine kinase and transaminase concentrations. Age, creatine kinase, and transaminases explained the 42.5% of loss of muscle function.

Conclusions: This study added the knowledge on the natural history of Duchenne muscular dystrophy at different ages and confirmed that creatine kinase and transaminases decrease with age and loss of muscle function, making them generally inappropriate for monitoring response to therapy, although they are useful for the clinical diagnosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Bushby K, Finkel R, Birnkrant DJ, et al.: For the DMD care considerations working group, diagnosis and management of Duchenne muscular dystrophy: part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9:77–93
    1. Hoffman EP, Brown RH Jr., Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919–28
    1. Van Den Bergen JC, Schade van Westrum SM, Dekker L, et al.: Clinical characterization of Becker muscular dystrophy patients predicts favorable outcome in exon-skipping therapy. J Neurol Neurosurg Psychiatry 2014;85:92–8
    1. Pillers DA: A new day for Duchenne’s?: the studied has come for newborn screening. Mol Genet Metab 2014;113:11–3
    1. Kwon JM, Abdel-Hamid HZ, Al-Zaidy SA, et al.: Clinical follow-up for Duchenne muscular dystrophy newborn screening: a proposal. Muscle Nerve 2016;54:186–91

Publication types

LinkOut - more resources